Journal of the American Society of Cytopathology

JASC is the official journal of the American Society of Cytopathology, and will reflect the values and priorities of the society. In 2012 and 2013, JASC will consist of special supplemental issues with the annual scientific meeting abstracts of the American Society of Cytopathology. Beginning in 2014, JASC will publish its regular bimonthly issues with cutting-edge original research of the highest standard. The Journal will seek to provide an exceptional forum for interaction and dissemination of original research and educational information in the field of cytopathology and other allied disciplines in medicine. The cross-disciplinary focus of the journal will ensure sharing of information with all readers involved in the practice of cytopathology and its related basic sciences, epidemiology and clinical oncologic disciplines.

JASC will endeavor to have a positive impact not only on all aspects of cancer diagnosis and treatment, but also on other human disease. JASC will publish original work emphasizing novel discoveries or clinicopathologic correlations in a patient-centered environment, technological advances in basic and translational research with emphasis on the development of personalized medicine, and new or improved molecular techniques and their novel application for diagnosis or monitoring of disease. Preference will also be given to original work demonstrating the scholarship of education in cytopathology including new innovative tools for continuing education and training as well as designing and implementing new assessment and evaluation techniques. JASC will lead the discipline of cytopathology by setting professional quality standards ensuring diagnostic excellence, advocating laboratory safety and quality, and inter-professional education for pathologists, cytotechnologists and all allied health care specialties. It will duly address and highlight issues relating to population health and public policy topics.